Shire sets higher spending targets

Shire Plc expects to increase its spending on research and development this year, even as it prepares to commit €428 million to complete its latest acquisition- an all-cash offer for Movetis NV of Belgium.

Full text available to subscribers only. Click here for information on subscribing to MedNous.

Location

Ireland